Creative Medical Technology Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Creative Medical Technology Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $3,880 per $100 of sales comes from others' credit, against $3,692 from others' credit three years earlier. Less money tied up than almost all Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
−$3,880Money owed to suppliers is larger than money owed by customers plus stock: $3,880 per $100 of sales comes from others' credit, against $3,692 from others' credit three years earlier.
Less money tied up than almost all Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 93%
Sales fell 93% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-93% / -59%In 3 years sales changed by -93% while total assets changed by -59%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
95%Of every $100 the company owns, $95 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 71% of Healthcare companies in United States.
Tangible Net Worth Ratio
95%Of every $100 of net worth, $95 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 80% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Creative Medical Technology Holdings, Inc. made a loss over the last year. Creative Medical Technology Holdings, Inc. owes $0.07 for every $1 it owns. Creative Medical Technology Holdings, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCreative Medical Technology Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.68The share price is 0.68 times Creative Medical Technology Holdings, Inc.'s book value per share, lower than 87% of Healthcare companies in United States.
Market cap
$6 MThe total market value of all of Creative Medical Technology Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 92% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$9 MWhat Creative Medical Technology Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.14Net worth divided by the number of shares. The share price of $0.77 is 0.7 times this, which is the P/B above.
Return on equity (ROE)
-77.9%Creative Medical Technology Holdings, Inc. lost 77.9% of its shareholders' money over the last year, lower than 64% of Healthcare companies in United States.
Owes vs Owns
0.07×Creative Medical Technology Holdings, Inc. owes $0.07 for every $1 it owns (low), lower than 91% of Healthcare companies in United States.
Dividend yield
NoneCreative Medical Technology Holdings, Inc. does not currently pay a dividend.
Revenue growth
-45%Revenue fell 45% in the year to Dec 2025, and shrank 59% a year on average over 3 years.
Profit growth
LossCreative Medical Technology Holdings, Inc. made a loss in each of the last two years.
Profit margin
-99916.8%Creative Medical Technology Holdings, Inc. lost $99917 for every $100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Creative Medical Technology Holdings, Inc.: $6 M ÷ $9 M (30 Jun 2026) = 0.7.
What is Creative Medical Technology Holdings, Inc.'s return on equity?
Creative Medical Technology Holdings, Inc. lost 77.9% of its shareholders' money over the last year, lower than 64% of Healthcare companies in United States.
How much does Creative Medical Technology Holdings, Inc. owe compared with what it owns?
Creative Medical Technology Holdings, Inc. owes $0.07 for every $1 it owns (low), lower than 91% of Healthcare companies in United States.
Does Creative Medical Technology Holdings, Inc. pay a dividend?
No. Creative Medical Technology Holdings, Inc. does not currently pay a dividend.
Is Creative Medical Technology Holdings, Inc.'s revenue growing?
Revenue fell 45% in the year to Dec 2025, and shrank 59% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.